Novo Nordisk A/S is a global healthcare company and world leader in Obesity and Diabetes care. Headquartered in Denmark, it discovers, develops, manufactures, and markets pharmaceutical products including GLP-1 receptor agonists (Ozempic, Wegovy, Saxenda), modern and human insulins, and a Rare disease portfolio covering growth hormone and haemophilia products. It employs over 69,500 people and markets products in approximately 170 countries.
Look up NVO using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on NVO, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/NVO (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.